Senior researcher, Tulane university school of medicine, United States
Mohamed Hassan is a distinguished researcher specializing in molecular oncology and translational medicine. He earned his Ph.D. from the University Hospital of Düsseldorf, Germany, focusing on Hepatitis C virus interactions with intracellular signaling. With extensive postdoctoral training in gastroenterology, pathology, and molecular tumor therapy, he has held academic positions in leading institutions across Germany, France, and the USA. His research spans cancer progression, drug resistance, and the tumor microenvironment, contributing to high-impact publications. Recognized globally for his scientific excellence, he has received prestigious awards, including the Italian Ministry of Health Award and the Japanese Society of Internal Medicine Award.
PROFESSIONAL PROFILE
Orcid
EDUCATION
- Ph.D. (2001), University Hospital of Düsseldorf, Germany – Research on Hepatitis C virus core protein interference in liver cells.
- M.Sc. (1996), University of Düsseldorf, Germany – Study on cDNA expression in malaria-immune mice.
- B.Sc. (1983), Zagazig University & University of Düsseldorf, Germany.
- Further Training: Teaching certification (University of Mississippi Medical Center, 2015), Clinical Research Associate (Germany, 2011), eLearning applications (University of Köln, 2008), and animal experimentation training (University of Düsseldorf, 2005).
EXPERIENCE
- Senior Postdoctoral Fellow & PI – Institut National de la Santé et de la Recherche Médicale, University of Strasbourg (2007-2013).
- Research Assistant Professor – Tulane University, USA (2016-2018); University of Strasbourg, France (2018-present).
- Instructor – University of Mississippi Medical Center (2013-2016).
- Postdoctoral Fellow – University Hospital of Düsseldorf (2001-2004).
- Research Assistant – University Hospital of Düsseldorf (1996-2001); University of Düsseldorf (1992-1996).
AWARDS AND HONORS
🏅 2016 – Italian Ministry of Health Award for Research & Innovation.
🏅 2016 – Award of Excellence in Reviewing by Spandido Publications.
🏅 2011 – Japanese Society of Internal Medicine Outstanding Researcher Award.
RESEARCH FOCUS
🔬 Cancer Biology – Investigating tumor progression, metastasis, and resistance mechanisms.
🧬 Molecular Oncology – Targeting non-receptor tyrosine kinases in cancer therapy.
💊 Translational Medicine – Developing novel therapeutic strategies against cancer stem-like cells.
🦠 Immuno-oncology – Exploring immune checkpoint inhibitors and their effects.
🧑⚕️ Clinical Research – Bridging molecular insights with patient-centered treatments.
PUBLICATIONS
📄 Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events – International Journal of Molecular Sciences (2024)
📄 Non-Receptor Tyrosine Kinases in Tumor Progression and Resistance – Cancers (2024)
📄 hTERT Epigenetics & Chemotherapy Guidance – International Journal of Molecular Sciences (2024)
📄 CD133-Dependent Activation in Melanoma Progression – Cells (2024)
📄 Mechanisms of Melanoma Progression & Treatment Resistance – Cancers (2024)
📄 Tumor Microenvironment as a Therapeutic Target in Melanoma – Cancers (2023)
📄 Toll-like Receptors in Antimicrobial Protein Expression – International Journal of Molecular Sciences (2023)
📄 Antimicrobial Proteins: Structure & Therapeutic Potential – Pharmaceutics (2022)
CONCLUSION
Mohamed Hassan is a leading figure in molecular oncology, contributing groundbreaking research in cancer progression and therapy resistance. His work has been recognized internationally, and he continues to drive impactful discoveries in translational medicine and immuno-oncology. His commitment to scientific excellence is evident in his numerous high-impact publications and global collaborations. 🚀